Binding Mechanism: Bypassing Classical Pathways
The classical immune response dictates that an antigen-presenting cell (APC) engulfs a foreign agent, degrades it internally, and displays fragments within the specialized cleft of a major histocompatibility complex (MHC) molecule. Superantigens act fundamentally differently, completely breaking this strict algorithm.
The main difference lies in the absence of processing. Superantigens do not require any preliminary intracellular processing or enzymatic cleavage inside antigen-presenting cells. They interact with receptors in their completely intact, native form.
The localization of this binding is also unique:
- The superantigen simultaneously interacts with an MHC class II molecule on the APC surface and with the T-cell receptor (TCR).
- Fixation occurs strictly outside the antigen-binding cleft (i.e., not in the active center where peptides are normally presented).
- The molecule attaches to the receptors "from the side," acting as a physical bridge that tightly anchors MHC class II and the TCR together.
Pathophysiological Effects and the Cytokine Storm
Because of this harsh cross-linking of receptors, the fine regulation of immunity is disrupted. Normally, an antigen activates only one specific clone of T lymphocytes capable of recognizing a particular threat. Superantigens, however, cause polyclonal activation.
This means a colossal number of different T-lymphocyte clones are involved simultaneously. Rapid, antigen-nonspecific proliferation begins, triggering a cascade of catastrophic reactions:
- Cytokine Hyperproduction. Millions of inappropriately activated T cells begin a massive release of biologically active substances, creating a life-threatening condition known as a "cytokine storm".
- Clinical Manifestations. Severe systemic inflammation develops, affecting the entire body.
- Tissue Destruction. An excess of cytokines and the aggressive activity of immune cells lead to damage to healthy host tissues.
- Apoptosis. The life cycle of T lymphocytes following such abnormal, super-intensive activation is rapidly exhausted, inevitably leading to their mass death (programmed cell death, or apoptosis).
Classification of Superantigens
Superantigens are generally divided into two major groups depending on which links of lymphocyte immunity they affect: T-cell and B-cell superantigens.
T-cell superantigens are the most studied group, causing the most prominent clinical manifestations (e.g., toxic shock syndrome). Main representatives:
- Staphylococci: produce enterotoxins and the specific toxic shock syndrome toxin (TSST).
- Streptococci: surface M protein and erythrogenic toxin possess superantigenic properties.
- Viruses: classical examples include Epstein-Barr virus antigens.
B-cell superantigens act through a different principle. They are immunoglobulin-binding proteins that can be of both microbial and human origin. Their pathogenic mechanism involves non-specific interaction with various random antibody (immunoglobulin) regions. In doing so, they completely bypass the classical binding to the variable regions of antibodies intended for precise antigen recognition.